Paradigm BioCapital Advisors LP 13D and 13G filings for Olema Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:45 pm Purchase |
2024-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA |
Paradigm BioCapital Advisors LP | 7,429,355 9.990% |
1,925,755 (+34.99%) |
Filing |
| 2024-11-14 4:34 pm Sale |
2024-09-30 | 13G | Olema Pharmaceuticals, Inc. OLMA |
Paradigm BioCapital Advisors LP | 5,503,600 9.600% |
-2,400,000 (-30.37%) |
Filing |
| 2024-02-14 4:08 pm Purchase |
2023-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA |
Paradigm BioCapital Advisors LP | 7,903,600 14.300% |
100,000 (+1.28%) |
Filing |
| 2023-09-13 5:22 pm Purchase |
2023-09-12 | 13G | Olema Pharmaceuticals, Inc. OLMA |
Paradigm BioCapital Advisors LP | 7,803,600 14.300% |
5,288,489 (+210.27%) |
Filing |
| 2023-04-10 4:33 pm Purchase |
2023-03-29 | 13G | Olema Pharmaceuticals, Inc. OLMA |
Paradigm BioCapital Advisors LP | 2,515,111 6.200% |
2,515,111 (New Position) |
Filing |